48.36
price up icon0.25%   0.12
 
loading

Qiagen Nv Borsa (QGEN) Ultime notizie

pulisher
04:56 AM

What drives Qiagen N.V. stock priceTremendous gains - Jammu Links News

04:56 AM
pulisher
Jul 18, 2025

What analysts say about Qiagen N.V. stockBreakout profit opportunities - Jammu Links News

Jul 18, 2025
pulisher
Jul 18, 2025

Qiagen Announces Significant Voting Rights Notification by BlackRock - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Favorable Government Support Fuels Germany's Biotech Innovation and Commercialization: Market to Surpass USD 94 Billion by 2034 Led by QIAGEN, Thermo Fisher Scientific, Illumina and Roche - yahoo.co

Jul 18, 2025
pulisher
Jul 15, 2025

Qiagen N.V. (NYSE:QGEN) is favoured by institutional owners who hold 79% of the company - simplywall.st

Jul 15, 2025
pulisher
Jul 15, 2025

Fivespan Said to Build Stake in Life Sciences Group Qiagen - MSN

Jul 15, 2025
pulisher
Jul 11, 2025

Qiagen and Gencurix partner for oncology tests - MSN

Jul 11, 2025
pulisher
Jul 11, 2025

Qiagen NV stock hits 52-week high at 48.82 USD By Investing.com - Investing.com South Africa

Jul 11, 2025
pulisher
Jul 11, 2025

QIAGEN Announces Managerial Share Transaction - TipRanks

Jul 11, 2025
pulisher
Jul 11, 2025

Qiagen NV stock hits 52-week high at 48.82 USD - Investing.com Australia

Jul 11, 2025
pulisher
Jul 08, 2025

QIAGEN N.V. to Release Results for Q2 2025 and Hold Webcast - Business Wire

Jul 08, 2025
pulisher
Jul 08, 2025

QIAGEN NV : Deutsche Bank maintains a Buy rating - MarketScreener

Jul 08, 2025
pulisher
Jul 03, 2025

Baptista Research Begins Qiagen Coverage at Hold - MarketScreener

Jul 03, 2025
pulisher
Jul 03, 2025

Qiagen Teams With Gencurix to Expand Digital PCR Cancer Assays - MSN

Jul 03, 2025
pulisher
Jul 02, 2025

Qiagen N : announces adjustment of conversion price under its US$500,000,000 Convertible Bonds due 2031 - MarketScreener

Jul 02, 2025
pulisher
Jul 02, 2025

Qiagen N : announces adjustment of conversion price under its US$500,000,000 Convertible Bonds due 2027 - MarketScreener

Jul 02, 2025
pulisher
Jun 30, 2025

Qiagen N.V.(NYSE: QGEN) dropped from Russell 1000 Dynamic Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Ex-Dividend Reminder: Comcast, Qiagen and HA Sustainable Infrastructure Capital - Nasdaq

Jun 30, 2025
pulisher
Jun 28, 2025

Qiagen Announces Managerial Share Transaction - TipRanks

Jun 28, 2025
pulisher
Jun 27, 2025

Qiagen N.V. (QGEN) Expands MRD Testing with Tracer and Foresight Partnerships - MSN

Jun 27, 2025
pulisher
Jun 27, 2025

QIAGEN Announces Election of Stephen Rusckowski as Chairman of S - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR - TradingView

Jun 27, 2025
pulisher
Jun 26, 2025

Qiagen (QGEN) Target Price Raised by B of A Securities | QGEN Stock News - GuruFocus

Jun 26, 2025
pulisher
Jun 26, 2025

Qiagen stock reaches 52-week high at 48.24 USD - Investing.com

Jun 26, 2025
pulisher
Jun 24, 2025

Here's Why Qiagen (QGEN) is a Strong Value Stock - Yahoo Finance

Jun 24, 2025
pulisher
Jun 23, 2025

Qiagen Announces BlackRock’s Significant Voting Rights Disclosure - TipRanks

Jun 23, 2025
pulisher
Jun 23, 2025

Qiagen (QGEN) Just Flashed Golden Cross Signal: Do You Buy? - yahoo.co

Jun 23, 2025
pulisher
Jun 21, 2025

Incyte (INCY) Teams Up with QIAGEN to Boost Blood Cancer Diagnostic Solutions - MSN

Jun 21, 2025
pulisher
Jun 19, 2025

QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership - BioSpace

Jun 19, 2025
pulisher
Jun 18, 2025

Incyte Stock Rises on QIAGEN Deal to Advance Blood Cancer Diagnostics - MSN

Jun 18, 2025
pulisher
Jun 18, 2025

Qiagen’s Voting Rights Notification Highlights BlackRock’s Influence - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

BlackRock’s Significant Stake in Qiagen Revealed - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

Qiagen (QGEN) Partners with Gencurix to Enhance Oncology Diagnos - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Qiagen, Gencurix Launch Oncology Testing Development Partnership - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Qiagen and Gencurix partner for oncology tests (QGEN:NYSE) - Seeking Alpha

Jun 18, 2025
pulisher
Jun 18, 2025

QIAGEN, GENCURIX announce QIAcuity Digital PCR IVD Assay Development Partnership - marketscreener.com

Jun 18, 2025
pulisher
Jun 17, 2025

QGEN Stock Rises in After Market Following Partnership With Incyte - MSN

Jun 17, 2025
pulisher
Jun 17, 2025

Qiagen and Incyte announce precision medicine collaboration - BioSpectrum Asia

Jun 17, 2025
pulisher
Jun 16, 2025

Should You Add QIAGEN Stock to Your Portfolio for Now? - MSN

Jun 16, 2025
pulisher
Jun 16, 2025

Qiagen and Incyte to develop diagnostic panel for myeloproliferative neoplasms - Medical Device Network

Jun 16, 2025
pulisher
Jun 16, 2025

QIAGEN, Incyte Partner to Develop NGS-Based Diagnostic Panel for Rare Blood Cancers - MarketScreener

Jun 16, 2025
pulisher
Jun 15, 2025

QIAGEN And Incyte Partner To Create New Test For Rare Blood Cancers - Nasdaq

Jun 15, 2025
pulisher
Jun 15, 2025

QIAGEN and Incyte Announce Precision Medicine Collaboration to D - GuruFocus

Jun 15, 2025
pulisher
Jun 15, 2025

QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs) | QGEN Stock News - GuruFocus

Jun 15, 2025
pulisher
Jun 15, 2025

QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs) - Yahoo Finance

Jun 15, 2025
pulisher
Jun 14, 2025

QIAGEN expands portfolio for MRD testing in oncology with two partnerships - MSN

Jun 14, 2025
pulisher
Jun 12, 2025

Qiagen Announces Significant Shareholding Notification - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView

Jun 12, 2025
diagnostics_research WAT
$287.53
price down icon 3.16%
diagnostics_research DGX
$166.91
price down icon 0.76%
$138.90
price down icon 3.12%
diagnostics_research LH
$243.72
price down icon 1.42%
diagnostics_research MTD
$1,194.85
price down icon 0.90%
diagnostics_research IQV
$160.63
price down icon 1.60%
Capitalizzazione:     |  Volume (24 ore):